Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use

INTRODUCTION: Our aim was to determine the rate of success of HFNO and its relationship with current treatments for severe COVID-19. METHOD: This was a cohort study including patients admitted for HFNO because of respiratory failure despite oxygen therapy through a facial mask. Care was standardized...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouissa, R., Le Guillou, C., Broudic, M., Markowicz, S., Curlier, E., Roger, P.-M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842410/
https://www.ncbi.nlm.nih.gov/pubmed/35176514
http://dx.doi.org/10.1016/j.idnow.2022.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842410/
https://www.ncbi.nlm.nih.gov/pubmed/35176514
http://dx.doi.org/10.1016/j.idnow.2022.02.006

Ejemplares similares